Premium Financials Agenda

Faça Login ou Cadastre-se para ter acesso completo.

Supercharge your analysis with exclusive data on more than 6000 companies.

All your companies centralized on a single place.

A powerful Screener with all companies and indicators available on the site.

All the companies you've bookmarked to learn more.

Compare up to 5 companies, using more than 900 exclusive indicators between Stocks, REITs, Ações and FIIs.

Review and analyze updated financials of more than 6.000 Stocks, REITs, FIIs and Ações.

See the most complete corporate Events Calendar in the world.

Don't miss anything regarding the companies that matter most. Join our discussions.

All material facts published in the last 90 days.

Get ahead with the best companies ranked by the community.

CLLS

CLLS

Price • Cellectis

CLLS

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

Historical stock price chart and annual return over the past years

CC

-90%

5 years

% Total

CLLS

-36%

5 years

Annual Return

CLLS